One-year outcomes of left main coronary artery stenting in patients with cardiogenic shock

Folia Cardiologica

Volumn 14, Issue 1, 2007, Pages 67-75

  Wiśniewska Szmyt, Joanna ^a   Kubica, Jacek ^a   Sukiennik, Adam ^a   Radomski, Marek ^a   Rychter, Marcin ^a   Jabłoński, Mirosław ^a   Białosyński, Tomasz ^a   Koziński, Marek ^a   Grabczewska, Zofia ^a   Grześk, Grzegorz ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Cardiogenic shock; Left main coronary artery stenosis; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE;

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; REOPERATION; RESTENOSIS; SURVIVAL RATE; SYMPTOM; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 34247485506     PISSN: 15074145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Goldberg RJ, Samad NA, Yarzebski J et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med, 1999; 340:1162-1168.
2. Hochman JS, Buller ChE, Sleeper LA et al. Cardiogenic shock complicating acute myocardial infarction - etiologies, management and outcome: a report from the SHOCK Trial Registry. J Am Coll Cardiol, 2000; 36: 1063-1070.
3. Van de Werf F, Ardissino D, Betriu A et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J, 2003; 24: 28-66.
4. Silber S, Albertsson P, Aviles FF et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J, 2005; 26: 804-847.
5. Smith SC, Feldman TE, Hirshfeld JW et al. ACC//AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation, 2006; 113 (1): 156-175; 113 (7): e166-e286.
6. Reiber JHC, Schiemanck LR, van der Zwet PMJ et al. QCA technical update 1995. In: de Feyter PJ, Di Mario C, Serruys PW (ed.) Quantitative coronary imaging. Barjesteh, Meeuwes & Co., Rotterdam 1995: 9-27.
7. Webb JG, Sanborn TA, Sleeper LA et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial registry. Am Heart J, 2001; 141: 964-970.
8. White HD, Assmann SF, Sanborn TA et al. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock. Results from the Should we Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Trial. Circulation, 2005; 112: 1992-2001.
9. Zeymer U, Vogt A, Zahn R et al. Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI). Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Eur Heart J, 2004; 25: 322-328.
10. Quigley RL, Milano CA, Smith R et al. Prognosis and management of anterolateral myocardial infarction in patients with severe left main disease and cardiogenic shock; the left main shock syndrome. Circulation, 1993; 88: 2987-3007.
11. Braunwald E, Antman EM, Beasley JW et al. ACC//AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol, 2002; 40: 1366-1374.
12. Morrow DA, Antman EM, Charlesworth A et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation an intravenous nPA for treatment of infarcting myocardium early II trial sub-study. Circulation, 2000; 102: 2031-2037.
13. Nashef SA, Roques F, Michel P et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg, 1999; 16: 9-13.
14. Lee SW, Hong MK, Lee ChW et al. Early and late clinical outcomes after primary stenting of the unprotected left main coronary artery stenosis in the setting of acute myocardial infarction. Int J Cardiol, 2004; 97: 73-76.
15. Marso SP, Steg G, Plokker T et al. Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience). Am J Cardiol, 1999; 83: 1513-1517.
16. Yamane M, Inoue S, Yamane A et al. Primary stenting for left main shock syndrome. EuroInterv, 2005; 1: 198-203.
17. Yip H-K, Chiung-Jen W, Mien-Cheng Ch et al. Effect of primary angioplasty on total or subtotal left main occlusion. Analysis of incidence, clinical features, outcomes and prognostic determinants. Chest 2001; 120: 1212-1217.
18. Tan WA, Tamai H, Park SJ et al.: for the ULTIMA investigators. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularisation in 279 patients. Circulation, 2001; 104: 1609-1614.
19. Antoniucci D, Valenti R, Migliorini A et al. Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation. Am J Cardiol,. 2002; 90: 353-357.
20. Chan AW, Chew DP, Bhatt DL et al. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol, 2002; 89: 132-136.
21. Giri S, Mitchel J, Azzar RR et al. Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol, 2002; 89: 126-131.
22. Black A, Cortina R, Bossi I et al. Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection. J Am Coll Cardiol, 2001; 37: 832-838.
23. Park SJ, Park SW, Hong MK et al. Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Am J Candiol, 2003; 91: 12-16.